SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005247
Filing Date
2021-04-29
Accepted
2021-04-29 16:06:57
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20210331x10q.htm   iXBRL 10-Q 1364340
2 EX-31.1 idra-20210331xex31d1.htm EX-31.1 14213
3 EX-31.2 idra-20210331xex31d2.htm EX-31.2 13923
4 EX-32.1 idra-20210331xex32d1.htm EX-32.1 7142
5 EX-32.2 idra-20210331xex32d2.htm EX-32.2 7751
6 GRAPHIC idra-20210331x10q004.jpg GRAPHIC 4421
7 GRAPHIC idra-20210331x10q012.jpg GRAPHIC 2260
8 GRAPHIC idra-20210331x10q013.jpg GRAPHIC 2434
  Complete submission text file 0001558370-21-005247.txt   6283648

Data Files

Seq Description Document Type Size
9 EX-101.SCH idra-20210331.xsd EX-101.SCH 47551
10 EX-101.CAL idra-20210331_cal.xml EX-101.CAL 39362
11 EX-101.DEF idra-20210331_def.xml EX-101.DEF 175723
12 EX-101.LAB idra-20210331_lab.xml EX-101.LAB 408965
13 EX-101.PRE idra-20210331_pre.xml EX-101.PRE 350640
14 EXTRACTED XBRL INSTANCE DOCUMENT idra-20210331x10q_htm.xml XML 1094978
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 21870519
SIC: 2836 Biological Products, (No Diagnostic Substances)